229 related articles for article (PubMed ID: 23508889)
1. Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis.
Wang L; Tang S; Wang Y; Xu S; Yu J; Zhi X; Ou Z; Yang J; Zhou P; Shao Z
Clin Exp Metastasis; 2013 Jun; 30(5):671-80. PubMed ID: 23508889
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD73 therapy impairs tumor angiogenesis.
Allard B; Turcotte M; Spring K; Pommey S; Royal I; Stagg J
Int J Cancer; 2014 Mar; 134(6):1466-73. PubMed ID: 23982901
[TBL] [Abstract][Full Text] [Related]
3. Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.
Zhou X; Zhi X; Zhou P; Chen S; Zhao F; Shao Z; Ou Z; Yin L
Oncol Rep; 2007 Jun; 17(6):1341-6. PubMed ID: 17487388
[TBL] [Abstract][Full Text] [Related]
4. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
5. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
[TBL] [Abstract][Full Text] [Related]
6. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
7. CD73 as a potential opportunity for cancer immunotherapy.
Ghalamfarsa G; Kazemi MH; Raoofi Mohseni S; Masjedi A; Hojjat-Farsangi M; Azizi G; Yousefi M; Jadidi-Niaragh F
Expert Opin Ther Targets; 2019 Feb; 23(2):127-142. PubMed ID: 30556751
[TBL] [Abstract][Full Text] [Related]
8. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation.
Niemelä J; Henttinen T; Yegutkin GG; Airas L; Kujari AM; Rajala P; Jalkanen S
J Immunol; 2004 Feb; 172(3):1646-53. PubMed ID: 14734746
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis.
Wirsdörfer F; de Leve S; Cappuccini F; Eldh T; Meyer AV; Gau E; Thompson LF; Chen NY; Karmouty-Quintana H; Fischer U; Kasper M; Klein D; Ritchey JW; Blackburn MR; Westendorf AM; Stuschke M; Jendrossek V
Cancer Res; 2016 May; 76(10):3045-56. PubMed ID: 26921334
[TBL] [Abstract][Full Text] [Related]
10. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression.
Bowser JL; Blackburn MR; Shipley GL; Molina JG; Dunner K; Broaddus RR
J Clin Invest; 2016 Jan; 126(1):220-38. PubMed ID: 26642367
[TBL] [Abstract][Full Text] [Related]
11. Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion.
Cappellari AR; Vasques GJ; Bavaresco L; Braganhol E; Battastini AM
Mol Cell Biochem; 2012 Jan; 359(1-2):315-22. PubMed ID: 21858682
[TBL] [Abstract][Full Text] [Related]
12. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Wang L; Fan J; Thompson LF; Zhang Y; Shin T; Curiel TJ; Zhang B
J Clin Invest; 2011 Jun; 121(6):2371-82. PubMed ID: 21537079
[TBL] [Abstract][Full Text] [Related]
13. CD73: an emerging checkpoint for cancer immunotherapy.
Chen S; Wainwright DA; Wu JD; Wan Y; Matei DE; Zhang Y; Zhang B
Immunotherapy; 2019 Aug; 11(11):983-997. PubMed ID: 31223045
[TBL] [Abstract][Full Text] [Related]
14. CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.
Airas L; Hellman J; Salmi M; Bono P; Puurunen T; Smith DJ; Jalkanen S
J Exp Med; 1995 Nov; 182(5):1603-8. PubMed ID: 7595232
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
16. The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.
Zukowska P; Kutryb-Zajac B; Toczek M; Smolenski RT; Slominska EM
Pharmacol Rep; 2015 Aug; 67(4):675-81. PubMed ID: 26321267
[TBL] [Abstract][Full Text] [Related]
17. CD73 mediates adhesion of B cells to follicular dendritic cells.
Airas L; Jalkanen S
Blood; 1996 Sep; 88(5):1755-64. PubMed ID: 8781432
[TBL] [Abstract][Full Text] [Related]
18. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
[TBL] [Abstract][Full Text] [Related]
19. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
[TBL] [Abstract][Full Text] [Related]
20. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
